Impedimed Ltd - Asset Resilience Ratio

Latest as of June 2025: 52.04%

Impedimed Ltd (IPD) has an Asset Resilience Ratio of 52.04% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Impedimed Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

AU$21.68 Million
≈ $15.34 Million USD Cash + Short-term Investments

Total Assets

AU$41.66 Million
≈ $29.48 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2007–2025)

This chart shows how Impedimed Ltd's Asset Resilience Ratio has changed over time. See IPD total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Impedimed Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see IPD stock market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents AU$21.68 Million 52.04%
Short-term Investments AU$0.00 0%
Total Liquid Assets AU$21.68 Million 52.04%

Asset Resilience Insights

  • Very High Liquidity: Impedimed Ltd maintains exceptional liquid asset reserves at 52.04% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Impedimed Ltd Industry Peers by Asset Resilience Ratio

Compare Impedimed Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Vitrolife AB
ST:VITR
Medical Devices 7.27%
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
Medical Devices 19.31%
Tellgen Corp
SHE:300642
Medical Devices 8.60%
Lumos Diagnostics Holdings Ltd
AU:LDX
Medical Devices 9.40%
T&R Biofab Co. Ltd
KQ:246710
Medical Devices 0.12%
Ok Biotech Co Ltd
TW:4155
Medical Devices 0.32%
Promimic AB
ST:PRO
Medical Devices 8.62%
Memphasys Ltd
AU:MEM
Medical Devices 0.00%

Annual Asset Resilience Ratio for Impedimed Ltd (2007–2025)

The table below shows the annual Asset Resilience Ratio data for Impedimed Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-06-30 52.04% AU$21.68 Million
≈ $15.34 Million
AU$41.66 Million
≈ $29.48 Million
+12.90pp
2024-06-30 39.14% AU$18.39 Million
≈ $13.01 Million
AU$46.99 Million
≈ $33.25 Million
+19.42pp
2023-06-30 19.71% AU$13.55 Million
≈ $9.59 Million
AU$68.74 Million
≈ $48.64 Million
-33.59pp
2022-06-30 53.30% AU$31.29 Million
≈ $22.14 Million
AU$58.70 Million
≈ $41.53 Million
+19.68pp
2021-06-30 33.62% AU$11.50 Million
≈ $8.14 Million
AU$34.20 Million
≈ $24.20 Million
+7.07pp
2020-06-30 26.55% AU$8.78 Million
≈ $6.21 Million
AU$33.06 Million
≈ $23.39 Million
-9.61pp
2019-06-30 36.16% AU$8.16 Million
≈ $5.78 Million
AU$22.58 Million
≈ $15.98 Million
-31.92pp
2018-06-30 68.08% AU$28.30 Million
≈ $20.02 Million
AU$41.57 Million
≈ $29.41 Million
-5.30pp
2017-06-30 73.38% AU$47.22 Million
≈ $33.41 Million
AU$64.34 Million
≈ $45.53 Million
--
2016-06-30 0.00% AU$0.00
≈ $0.00
AU$90.57 Million
≈ $64.08 Million
--
2012-06-30 0.16% AU$31.00K
≈ $21.93K
AU$19.61 Million
≈ $13.88 Million
+0.02pp
2011-06-30 0.14% AU$31.00K
≈ $21.93K
AU$22.80 Million
≈ $16.14 Million
-0.08pp
2008-06-30 0.21% AU$31.00K
≈ $21.93K
AU$14.52 Million
≈ $10.27 Million
-0.47pp
2007-06-30 0.68% AU$148.00K
≈ $104.72K
AU$21.79 Million
≈ $15.42 Million
--
pp = percentage points

About Impedimed Ltd

AU:IPD Australia Medical Devices
Market Cap
$12.98 Million
AU$18.35 Million AUD
Market Cap Rank
#26202 Global
#1247 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.06
All Time High
AU$1.68
About

ImpediMed Limited, a medical technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices and software services in Australia, Europe, the United States, and internationally. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema, which uses bioimpedance measurements to assess fluid levels and tissue compositi… Read more